Ad
BRFS - BRF S A Stock Trading
About | BRF S.A. (NYSE:BRFS)
Not available
Quote | BRF S.A. (NYSE:BRFS)
| Last: | $3.01 |
|---|---|
| Change Percent: | 0.99% |
| Open: | $3.01 |
| Close: | $3.01 |
| High: | $3.065 |
| Low: | $2.975 |
| Volume: | 2,254,250 |
| Last Trade Date Time: | 12/04/2023 03:00:00 am |
News | BRF S.A. (NYSE:BRFS)
-
2023-11-14 16:23:07 ET BRF S.A. (BRFS) Q3 2023 Results Conference Call November 14, 2023 08:30 AM ET Company Participants Miguel Gularte - Chief Executive Officer Fabio Mariano - Chief Financial Officer Conference Call Participants Ricardo Alves - Morgan ...
-
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Message Board Posts | BRF S.A. (NYSE:BRFS)
| Subject | By | Source | When |
|---|---|---|---|
| Bought a bunch here today! lets ride! 2$ | Afterhoursearnings3 | investorshub | 04/03/2023 8:28:06 PM |
| Shorted all of Latin America. Was a profitable | DarkPool | investorshub | 03/27/2023 4:13:20 PM |
| Well shows how little you know. But not | DarkPool | investorshub | 03/27/2023 10:19:57 AM |
| You never did fake trader. This is going | TrendTrade2016 | investorshub | 03/26/2023 2:44:18 PM |
| Let me know where. Just gonna borrow em ;) | DarkPool | investorshub | 03/24/2023 6:18:38 PM |
News, Short Squeeze, Breakout and More Instantly...
BRF S.A. Company Name:
BRFS Stock Symbol:
NYSE Market:
Ad
-
As of Nov. 30, 2023, four stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria ...
-
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
-
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...